Viogen Pharmaceuticals and Tirzepatide: Making Sense of the Name Before You Decide

Who makes tirzepatide, and does Viogen have a role in the UK licensed supply chain?

Tirzepatide was developed by Eli Lilly, and the UK Mounjaro licence belongs to Eli Lilly. The medicine is manufactured to tightly controlled standards and enters the UK through an authorised supply chain before reaching GPhC-registered pharmacies. Viogen Pharmaceuticals is a name that surfaces in searches related to tirzepatide, but it does not hold a UK marketing authorisation for tirzepatide as a weight-loss medicine. If you have seen Viogen-branded tirzepatide offered online, it is important to understand what that means in practice: any tirzepatide product sold in the UK under a name other than Mounjaro (or supplied without a valid prescription following clinical assessment) falls outside the licensed, regulated framework the MHRA oversees.

That distinction matters because counterfeit weight-loss pens are a documented problem in the UK. The MHRA has warned publicly about fake pens sold through social media and unverified websites, including some that contained insulin rather than the stated medicine. The question of which company made your pen is not a technicality; it is a safety question. Eli Lilly authorised supplier relationships (the chain from manufacturer to licensed UK pharmacy) are the only route the regulator sanctions. To learn more about how Mounjaro reaches UK patients through the licensed supply chain, the Mounjaro pharmaceutical company page covers the manufacturer's background in detail.

The decision: what to weigh up if you have seen tirzepatide advertised under unfamiliar names

Finding tirzepatide advertised under names you do not recognise (whether that is Viogen or anything else) puts you at a fork in the road. On one side: a product whose provenance you cannot verify, supplied without the clinical assessment a prescription requires. On the other: the licensed medicine, Mounjaro, supplied by a GPhC-registered pharmacy after a prescriber has reviewed your health history, weight, and any medicines you already take.

The factors worth thinking through are straightforward. First, is there a prescription involved? Tirzepatide is a Prescription-Only Medicine under the Human Medicines Regulations 2012; supplying it without a valid prescription is unlawful, and purchasing it that way puts the risk squarely on you. Second, can you verify the pharmacy? The GPhC publishes a public register at pharmacyregulation.org where you can check whether any pharmacy holds a valid registration, including the one offering what you are looking at. Third, what does the price tell you? Tirzepatide's list price rose substantially in 2025; pens priced far below the market range are a red flag, not a bargain. For broader context on what private tirzepatide costs through legitimate routes, the Mounjaro prices page sets out the realistic picture honestly.

You can also explore tirzepatide's clinical background and how it differs from other weight-loss medicines if you are still in the research phase.

Who tirzepatide is licensed for, and what the prescriber is actually checking

Even with the genuine Eli Lilly medicine, tirzepatide is not suitable for everyone. The UK licence covers adults with a BMI of 30 or above, or 27 and above if at least one weight-related health condition is present, conditions such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone is never the whole picture; the prescriber looks at your overall health, your current medications, and your medical history.

Treatment is not recommended during pregnancy, while breastfeeding, or when trying to conceive. It is also not licensed for anyone under 18. Certain conditions (including a personal or family history of medullary thyroid carcinoma) require careful discussion before any GLP-1 medicine is considered. The NHS patient information for tirzepatide on NHS.uk sets out the full contraindications in plain language, and it is worth reading alongside any consultation.

The storage routine is simple: Mounjaro pens live in the fridge, ideally somewhere you will not forget them, a shelf in the fridge door works well for most people. The exact window for keeping a pen at room temperature is in the Patient Information Leaflet and should always be followed. Our FAQs page covers common practical questions about storage and starting treatment.

How treatment through a regulated UK pharmacy actually works

Understanding the process demystifies a lot of the anxiety around online prescribing. At a GPhC-registered service, the process has clear stages: you complete a clinical consultation, providing your health history, current medications, and verifiable weight. A prescriber (a qualified, registered individual, not automated software) reads your answers and decides whether treatment is appropriate. If it is, a prescription is issued; if it is not, you are told why and pointed toward alternatives. Nothing about that process should feel rushed or anonymous.

At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber before any prescription is issued. Mounjaro is sourced through Eli Lilly's authorised UK supply chain. The pharmacy's GPhC premises registration is 9012878, verifiable directly on the GPhC register. You can also read about the clinical team behind the service on the clinical team page. If you are weighing up which pharmacy to use, the guide to Mounjaro pharmacies explains what to check before you commit. The weight-loss treatment overview is a good starting point if you are still deciding whether tirzepatide is the right fit for your situation.